Transforming growth factor β1 inhibits expression of NKP30 and NKG2d receptors: Consequences for the NK-mediated killing of dendritic cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 7, 2003, Pages 4120-4125

  Castriconi, Roberta ^a   Cantoni, Claudia ^a,c   Della Chiesa, Mariella ^a   Vitale, Massimo ^b   Marcenaro, Emanuela ^a   Conte, Romana ^b   Biassoni, Roberto ^b   Bottino, Cristina ^c   Moretta, Lorenzo ^a,c   Moretta, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; NATURAL KILLER CELL RECEPTOR NKG2D; NKP30 RECEPTOR; RECEPTOR PROTEIN; RECOMBINANT INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; IMMUNOGLOBULIN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL ACTIVATING RECEPTORS; NCR3 PROTEIN, HUMAN; PRIMER DNA; RECOMBINANT PROTEIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER SUSCEPTIBILITY; CELL KILLING; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; TARGET CELL; TRANSCRIPTION REGULATION; TUMOR CELL DESTRUCTION; TUMOR CELL LINE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; CELL SURVIVAL; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-2; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0037388134     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0730640100     Document Type: Article

References (33)

1. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C. & Moretta, L. (1996) Annu. Rev. Immunol. 14, 619-648.
2. Lanier, L. L. (1998) Annu. Rev. Immunol. 16, 359-393.
3. Long, E. O. (1999) Annu. Rev. Immunol. 17, 875-904.
4. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R. & Moretta, L. (2001) Annu. Rev. Immunol. 19, 197-223.
5. Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C. & Moretta, L. (2000) Immunol. Today 21, 228-234.
6. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. & Spies, T. (1999) Science 285, 727-729.
7. Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A. & Moretta, L. (2001) Eur. J. Immunol. 31, 1076-1086.
8. Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L. & Moretta, A. (1999) Eur. J. Immunol. 29, 1656-1666.
9. Costello, R. J., Sivori, S., Marcenaro, E., Lafage-Pochiutaloff, M., Mozziconacci, M. J., Reviron, D., Gastaud, J. A., Pende, D., Olive, D. & Moretta, A. (2002) Blood 99, 3661-3667.
10. Rook, A. H., Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Sporn, M. B., Burlington, D. B., Lane, H. C. & Fauci, A. S. (1986) J. Immunol. 136, 3916-3920.
11. Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B. & Fauci, A. S. (1986) J. Exp. Med. 163, 1037-1050.
12. Bellone, G., Aste-Amezaga, M., Trinchieri, G. & Rodeck, U. (1995) J. Immunol. 155, 1066-1073.
13. Gorelik, L. & Flavell, R. A. (2002) Nat. Rev. Immunol. 2, 46-53.
14. Campbell, J. J., Qin, S., Unutmaz, D., Soler, D., Murph, K. E., Hodge, M. R., Wu, L. & Butcher, E. C. (2001) J. Immunol. 166, 6477-6482.
15. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. & Münz, C. (2002) J. Exp. Med. 195, 343-351.
16. Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N. M. (2002) J. Exp. Med. 195, 335-341.
17. Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G. & Trinchieri, G. (2002) J. Exp. Med. 195, 327-333.
18. Berking, C., Takemoto, R., Schaider, H., Showe, L., Satyamoorthy, K., Robbins, P. & Herlyn, M. (2001) Cancer Res. 61, 8306-8316.
19. Pasche, B. J. (2001) J. Cell. Physiol. 186, 153-168.
20. Bergmann, L., Schui, D. K., Brieger, J., Weidmann, E., Mitrou, P. S. & Hoelzer, D. (1995) Exp. Hematol. 23, 1574-1580.
21. Schena, M., Gaidano, G., Gottardi, D., Malavasi, F., Larsson, L. G., Nilsson, K. & Caligaris-Cappio, F. (1992) Leukemia 6, 120-125.
22. Kim, S. J., Kehrl, J. H., Burton, J., Tendler, C. L., Jeang, K. T., Danielpour, D., Thevenin, C., Kim, K. Y., Sporn, M. B. & Roberts, A. B. (1990) J. Exp. Med. 172, 121-129.
23. Bertone, S., Schiavetti, F., Bellomo, R., Vitale, C., Ponte, M., Moretta, L. & Mingari, M. C. (1999) Eur. J. Immunol. 29, 23-29.
24. Feldmann, M., Brennan, F. M. & Maini, R. N. (1996) Annu. Rev. Immunol. 14, 397-440.
25. Moore, K. W., de Waal-Malefyt, R., Coffman, R. L. & O'Garra, A. (2001) Annu. Rev. Immunol. 19, 683-765.
26. Naohiro, S., Yoshiki, T., Masahiro, T. & Kohji, E. (1999) J. Immunol. 163, 242-249.
27. Moretta, A. (2003) Nat. Rev. Immunol. 2, 957-965.
28. Zitvogel, L. (2002) J. Exp. Med. 195, 9-14.
29. Wilson, J. L., Heffler, L. C., Charo, J., Scheynius, A., Bejarano, M. T. & Ljunggren, H. G. (1999) J. Immunol. 163, 6365-6370.
30. Spaggiari, G. M., Carosio, R., Pende, D., Marcenaro S., Rivera, P., Zocchi, M. R., Moretta, L. & Poggi, A. (2000) Eur. J. Immunol. 31, 1656-1665.
31. Carbone, E., Terrazzano, G., Ruggiero, G., Zanzi, D., Ottaiano, A., Manzo, C., Karre, K. & Zappacosta, S. (1999) Eur. J. Immunol. 29, 4022-4029.
32. Morelli, A. E., Zahorchak, A. F., Larregina, A. T., Colvin, B. L., Logar, A. J., Takayama, T., Falo, L. D. & Thomson, A. W. (2001) Blood 98, 1512-1523.
33. Zhou, L. J. & Tedder, T. F. (1995) Blood 86, 3295-3301.